The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
That really is pathetic General Oz. It's like saying that Manchester City are useless because they played in the lower leagues a few years ago. Actually you have cheered me up - if that is the best you can come up with your barrell must be scraped clean!
That's one way of looking at it Bleep and a valid one. However I prefer the optimistic view that the results for AVA6000 will be so good that the company is looking for funds to promote the other amazing products in the pipeline. Let's hope for a VERY Happy New Year!
Merry Christmas Everyone !
That's one way of looking at it Bleep and a valid one. However I prefer the optimistic view that the results for AVA6000 will be so good that the company is looking for funds to promote the other amazing products in the pipeline. Let's hope for a VERY Happy New Year!Merry Christmas Everyone !
Did anyone else see this earlier today?
The item was from St.James Hospital, which we all know is one of our trial hospitals and described great progress in cancer treatment. There was a description of the AVCT treatment working as Alastair Smith has described, and the radio ligand treatment, I believe, although the companies involved were not named. It was very positive in tone.
5/5 - #Vanadium based #VRFB flow batteries exist at scale NOW, are much safer than the alternatives and can even be made more compact than #LithiumIon #BESS systems.
https://t.co/Dv1utzryWA
Birdieman
Posts: 17
Price: 149.00
No Opinion
I had my jab this morning. I asked the presiding doctor if he had heard of the Synairgen treatment. He said he had heard that it was very good. I thought you would all like to know.
Covid stocks are out of favour because people think it's all over, but there is no final whistle in sight and there will be plenty of time, considering the market is worldwide, for tests and therapeutics to thrive. It will be much slower than I first calculated, but it will happen.
This RNS was not bad news, there is lots of good stuff in there.
Try again - the price depends on what the market makers are trying to do. It has little to do with buys and sells. If they want to stir the market up they will change the price quite dramatically for no apparent reason. Trust your own research, don't worry about the current price.
I have just gone back and read the unwarranted and cowardly attacks on you Ken and I was appalled. You have been a great asset to this board and I have never doubted your integrity. Keep up that great work and please give my best wishes to your wife.
The only thing, apart from the sp, that has changed is the news that we won't get any results for five to six weeks. However all the indications are good. There is positive stuff leaking out from the first trial, the publicity is extensive and positive too and the company are preparing to meet the demand. I am going to see it through but dyor.
1. A guy internationally renowned for his ability to sell worldwide takes over the distribution of our product.
2. Avacta and Medusa19 are clearly absolutely confident that the test will be approved or they wouldn't invest heavily in the project.